Revenue Growth and Financial Performance
Guardian Pharmacy reported a revenue increase of 20% to $377 million, driven by both organic growth and acquisitions. Adjusted EBITDA grew 19% to $27 million, with margins holding steady at 7.2%.
Resident Growth
The company experienced a 13% growth in resident count, reaching nearly 204,000 residents, primarily due to new facility partnerships and expansions.
Acquisitions in Pacific Northwest
Guardian Pharmacy successfully acquired pharmacies in Oregon and Washington, expanding its footprint in the Pacific Northwest and enhancing its growth potential in the region.
Increased Guidance for 2025
The company raised its full-year revenue guidance to $1.43 billion to $1.45 billion and adjusted EBITDA guidance to $104 million to $106 million, reflecting solid growth expectations.
Strong Financial Position
Guardian Pharmacy ended the quarter with $36 million in cash, highlighting strong cash generation and no debt outstanding under its credit facility.